Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Nissen

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Journal of Cachexia, Sarcopenia and Muscle|October 5, 2021
Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient-reported outcomes in pancreatic cancer cachexiaGillian Gresham, Veronica R Placencio-Hickok, Marie Lauzon, et al.
Gastroenterology|October 6, 2009
MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidatesAruna Subramanian, Mark Sulkowski, Burc Barin, et al.
Gastro Hep Advances|August 12, 2024
COVID-19 Pandemic Impact on Diagnosis, Stage, and Treatment of Hepatocellular Carcinoma in the United StatesBhupinder Kaur, Yee Hui Yeo, Jeff Liang, et al.
Hepatology (Baltimore, Md.)|April 16, 2022
Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United StatesJoseph C Ahn, Marie Lauzon, Michael Luu, et al.
Clinical and Translational Gastroenterology|June 3, 2024
Impact of the Early COVID-19 Pandemic on Incidence and Outcomes of Hepatocellular Carcinoma in the United StatesJeff Liang, Yi-Te Lee, Yee Hui Yeo, et al.
The American Journal of Gastroenterology|August 10, 2023
Immunotherapy and Transarterial Radioembolization Combination Treatment for Advanced Hepatocellular CarcinomaYee Hui Yeo, Jeff Liang, Marie Lauzon, et al.
Liver Cancer|November 1, 2021
Comparison of Surgical Resection and Systemic Treatment for Hepatocellular Carcinoma with Vascular Invasion: National Cancer Database AnalysisRajalakshmi Govalan, Marie Lauzon, Michael Luu, et al.
Ebiomedicine|January 13, 2019
A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancerRichard Tuli, Stephen L Shiao, Nicholas Nissen, et al.
Annals of Surgery|February 25, 2021
A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic CancerDaniel Brock Hewitt, Nicholas Nissen, Hassan Hatoum, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 15, 2025
Enhancing management of pancreatic cancer: impact of a same day multidisciplinary clinic on access to guideline-directed careMatthew I Ebia, Anser A Abbas, Abrahm Levi, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Journal of Cachexia, Sarcopenia and Muscle|October 5, 2021
Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient-reported outcomes in pancreatic cancer cachexiaGillian Gresham, Veronica R Placencio-Hickok, Marie Lauzon, et al.
Gastroenterology|October 6, 2009
MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidatesAruna Subramanian, Mark Sulkowski, Burc Barin, et al.
Gastro Hep Advances|August 12, 2024
COVID-19 Pandemic Impact on Diagnosis, Stage, and Treatment of Hepatocellular Carcinoma in the United StatesBhupinder Kaur, Yee Hui Yeo, Jeff Liang, et al.
Hepatology (Baltimore, Md.)|April 16, 2022
Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United StatesJoseph C Ahn, Marie Lauzon, Michael Luu, et al.
Clinical and Translational Gastroenterology|June 3, 2024
Impact of the Early COVID-19 Pandemic on Incidence and Outcomes of Hepatocellular Carcinoma in the United StatesJeff Liang, Yi-Te Lee, Yee Hui Yeo, et al.
The American Journal of Gastroenterology|August 10, 2023
Immunotherapy and Transarterial Radioembolization Combination Treatment for Advanced Hepatocellular CarcinomaYee Hui Yeo, Jeff Liang, Marie Lauzon, et al.
Liver Cancer|November 1, 2021
Comparison of Surgical Resection and Systemic Treatment for Hepatocellular Carcinoma with Vascular Invasion: National Cancer Database AnalysisRajalakshmi Govalan, Marie Lauzon, Michael Luu, et al.
Ebiomedicine|January 13, 2019
A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancerRichard Tuli, Stephen L Shiao, Nicholas Nissen, et al.
Annals of Surgery|February 25, 2021
A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic CancerDaniel Brock Hewitt, Nicholas Nissen, Hassan Hatoum, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 15, 2025
Enhancing management of pancreatic cancer: impact of a same day multidisciplinary clinic on access to guideline-directed careMatthew I Ebia, Anser A Abbas, Abrahm Levi, et al.
Pageof 7